science wire

« BACK

Health



Results 401 - 450 of 18856.
« Previous 1 ... 5 6 7 8 9 10 11 12 13 ... 378 Next »


Linguistics / Literature - Health - 31.08.2019

Health - Social Sciences - 30.08.2019
Summertime at Stanford - a time for two rising seniors to do gender-related research
Summertime at Stanford - a time for two rising seniors to do gender-related research
As Susan Heck Interns, Julia Pandolfo and Sophia Hu spent the summer working full time on their individual research projects at the Clayman Institute for Gender Research.

Health - Materials Science - 30.08.2019
Medicine for tomorrow
How can the latest findings from materials science be used in medical practice to develop innovative diagnostic and therapeutic concepts' Empa researchers, physicians from the Cantonal Hospital of St

Pharmacology - Health - 30.08.2019
Novartis ofatumumab demonstrates superiority versus Aubagio in two head-to-head Phase III multiple sclerosis studies
In ASCLEPIOS I and II, ofatumumab (OMB157) met primary endpoints to reduce the annualized relapse rate over Aubagio * (teriflunomide) in patients with relapsing forms of MS (RMS) Key secondary endpoi

Health - Pharmacology - 29.08.2019

Pharmacology - Health - 29.08.2019
European Commission approves Roche’s Tecentriq in combination with Abraxane for people with PD-L1-positive, metastatic triple-negative breast cancer
The Tecentriq combination marks the first cancer immunotherapy regimen to be available in Europe for triple-negative breast cancer - an aggressive and difficult-to-treat disease Approval based on the

Pharmacology - Health - 29.08.2019
Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq
This launch represents an important step in Roche's personalised healthcare strategy to fit treatments to patients who can benefit most from a specific medicine Each year 300,000 patients around the

Pharmacology - Health - 28.08.2019
New patient test could tell GPs if infections are antibiotic resistant in under two hours
New patient test could tell GPs if infections are antibiotic resistant in under two hours
A new rapid patient test which could identify whether bacteria isolated from clinical samples are antibiotic resistant in under two hours is being trialled on a range of antibiotics commonly used to treat urinary tract infections (UTIs).

Health - Materials Science - 26.08.2019
3D printed salt template for bioresorbable bone implants
3D printed salt template for bioresorbable bone implants
With the help of a 3D printed salt template, ETH researchers have succeeded in producing magnesium scaffolds with structured porosity that are suitable for bioresorbable bone implants. For the treatment of complex bone fractures or even missing bone parts, surgeons typically deploy metal implants. In this context, an attractive alternative to the traditional materials like bioinert titanium are biodegradable magnesium and its alloys.

Health - 26.08.2019
Exoskeleton Research Takes Steps Forward, Thanks To Personal Connection
John Mangual grew up watching his mother limp. Amy Mangual had broken her leg, and lived with ligament and tendon problems that lead to chronic ankle instability.

Chemistry - Health - 25.08.2019
Chemist James Trudell, whose research led to greater understanding of anesthetics, dies
For five decades, James Trudell studied how anesthetics work on the human body to cause unconsciousness. James Trudell, PhD, a Stanford Medicine chemist who spent 50 years hunting down molecular clues to help make anesthetic drugs safer for patients, died July 29 at his home in Woodside, California, with his wife by his side.

Health - Life Sciences - 21.08.2019
Mechanical forces impact immune response in the lungs
When the body is fending off an infection, there are changes in temperature, pH balance, and metabolism. Yale researchers wondered if yet other factors might come into play, and in a recent study, confirmed that mechanical forces also influence the immune response. The research team explored the matter by focusing on studies of the lungs where breathing creates pressure inside tiny airs sacs called alveoli.

Health - Innovation - 20.08.2019
ICR joins Imperial’s Academic Health Science Centre partnership
The Institute of Cancer Research, London, has joined the Imperial College Academic Health Science Centre (AHSC).

Innovation - Health - 20.08.2019
3D printing of silicone components
3D printing of silicone components
ETH spin-off Spectroplast has developed a method to make silicone products using a 3D printer. The young company now plans to bring to market customised medical products such as hearing aids, breast prosthesis for breast cancer patients and eventually even artificial heart valves.

Pharmacology - Health - 19.08.2019
Novartis to present new Entresto HFpEF and HFrEF data at ESC Congress 2019
PARAGON-HF trial will provide Entresto (sacubitril/valsartan) Phase III full results in heart failure with preserved ejection fraction (HFpEF)   New PROVE-HF and EVALUATE-HF studies will highlight Entresto's direct impact on the heart in heart failure with reduced ejection fraction (HFrEF)   New PIONEER-HF and TRANSITION-HF findings will advance understanding of Entresto use in patients hospitalized for decompensated HFrEF following stabilizatio

Health - Innovation - 19.08.2019

Pharmacology - Health - 16.08.2019
FDA approves Roche’s Rozlytrek (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours
First FDA-approved treatment designed to target both ROS1 and NTRK that also shows response in cancer that has spread to the brain Roche's first FDA-approved tumour-agnostic medicine Roche today announced that the US Food and Drug Administration (FDA) has approved Rozlytrek?

Pharmacology - Health - 16.08.2019
FDA approves Roche’s RozlytrekTM (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours
First FDA-approved treatment designed to target both ROS1 and NTRK that also shows response in cancer that has spread to the brain Roche's first FDA-approved tumour-agnostic medicine Roche today announced that the US Food and Drug Administration (FDA) has approved Rozlytrek?

Health - Life Sciences - 15.08.2019
Major award for two Bernese medical projects
Major award for two Bernese medical projects
Prestigious grants from the USA go to two Bernese researchers: the biomedical scientists Marianna Kruithof-de Julio and Robert Rieben were the only researchers in Switzerland to receive a grant under

Health - 09.08.2019
Genetic analyses indicate that the effect of being overweight and obesity on cancer risk is at least double what was previously thought
The effect of being overweight and obesity on risk of cancer is at least twice as large as previously thought according to new findings by an international research team that included University of Bristol academics.

Health - Pharmacology - 07.08.2019
Tiny biodegradable circuits for releasing painkillers inside the body
Tiny biodegradable circuits for releasing painkillers inside the body
EPFL researchers have developed biodegradable microresonators that can be heated locally with a wireless system.

Health - 05.08.2019
Doctors’ attitudes toward lesbians and gays shaped early in medical school
Attitudes towards lesbians and gay men can be shaped early on in medical training, with early-career doctors expressing less bias towards sexual minorities two years after medical school the more contact and favorable interactions they had with members of the LGBT community during medical school. Conversely, the more negative views students were exposed to about sexual minorities during medical school the greater the bias they exhibited by the second year of their medical residency, researchers from Yale and Oregon Health & Science University report Aug.

Pharmacology - Health - 05.08.2019
Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer
IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in previously untreated advanced bladder cancer Data will be shared with health authorities globally, including

Health - 05.08.2019
Sepsis plan needs action
Doctors from leading Australian institutions including The University of Queensland have called on the government to implement a national action plan to fight one of Australia's biggest killer diseases, sepsis.

Health - Environment - 02.08.2019
Healthcare industry is a major source of harmful emissions
Climate change presents an unprecedented public health emergency and the global healthcare sector is contributing to the worldwide crisis, argues Jodi Sherman, M.D. , associate professor of anesthesiology at the Yale School of Medicine in a commentary published Aug.

Health - Career - 02.08.2019
Scientists win ERC grants for 'blue skies' research
Scientists win ERC grants for ’blue skies’ research
Two researchers have won prestigious European Research Council (ERC) Proof of Concept grants to explore frontier research.

Social Sciences - Health - 31.07.2019
Researchers receive $17 million grant to fight opioid addiction in prisons
It's estimated that more than 130 people die every day from opioid-related drug overdoses.

Life Sciences - Health - 31.07.2019
Protective protein not only guards against DNA damage, but could help better target fast-growing cancer cells
The discovery that an essential protein plays a protective role during cell division, could open the door to better targeted treatment of fast-growing cancer cells. Polo-like kinase (PLK1) was previously thought to have a major function - helping chromosome alignment during mitosis for cell division.

Pharmacology - Health - 30.07.2019
Yale and Mayo Clinic awarded FDA grant to study opioid prescribing and use
Yale University and Mayo Clinic have been awarded a grant for up to $5.3 million over two years by the U.S. Food and Drug Administration (FDA) to study patients' experiences with pain and use of opioids prescribed for acute pain. This project is part of the Center of Excellence in Regulatory Science and Innovation (CERSI) , a joint effort between Yale, Mayo Clinic, and the FDA.

Health - 30.07.2019
Online resource to help sufferers ease back pain
A comprehensive tool to help people manage back pain has been developed by a team of international health experts led by University of Queensland researchers.
« Previous 1 ... 5 6 7 8 9 10 11 12 13 ... 378 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |